Updated:
Yanghe Biomedicine Industry Investment
Yanghe Biomedicine Industry Investment is a private equity based in Guangzhou; the Altss profile covers its classification, headquarters, registration, AUM...
Yanghe Biomedicine Industry Investment
Yanghe Biomedicine Industry Investment is a private equity firm based in Guangzhou, China. It focuses on venture capital investments.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Guangzhou
Corporate office
Guangzhou, China
Sector focus
Frequently asked questions
What types of companies does Yanghe Biomedicine Industry Investment target?
The firm invests across biopharma, medical devices, diagnostics, and digital health. It participates from seed and start-up phases through growth equity, targeting companies developing new chemical entities, biologics, advanced therapeutic platforms, and medtech innovations. The firm's focus aligns with Chinese industrial policy favoring domestic alternatives to imported drugs and devices.
What is the firm's geographic investment focus?
The firm deploys capital predominantly within mainland China, concentrating on the country's primary life science innovation hubs — notably the Greater Bay Area (Guangzhou, Shenzhen), Shanghai's Zhangjiang cluster, and Beijing's Zhongguancun ecosystem. It has not disclosed any cross-border investment activity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: